Connective tissue diseases: Bosentan for SSc: Long-term outcomes in PAH and efficacy for Raynaud phenomenon

被引：0
|
作者：
Price S.
机构：
来源：
Nature Reviews Rheumatology | 2010年 / 6卷 / 3期
关键词：
D O I：
10.1038/nrrheum.2010.6
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：117 / 117
相关论文
共 50 条
  • [1] SAFETY OF LONG TERM BOSENTAN TREATMENT IN CONNECTIVE TISSUE DISEASES
    Melchor, S.
    Joven, B. E.
    Carreira, P. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S162 - S162
  • [2] Long term iloprost therapy of severe Raynaud's phenomenon in connective tissue diseases.
    Spano, A
    Loi, G
    Bossa, RD
    Venditti, C
    Oriente, A
    Cimmino, M
    Lupo, A
    Del Puente, A
    Oriente, P
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S330 - S330
  • [3] NIFEDIPINE AND RAYNAUD PHENOMENON ASSOCIATED WITH CONNECTIVE-TISSUE DISEASES
    KAHAN, A
    WEBER, S
    AMOR, B
    MENKES, CJ
    HODARA, M
    DEGEORGES, M
    INTERNATIONAL ANGIOLOGY, 1985, 4 (02) : 221 - 223
  • [4] Long-term effects of bosentan in pulmonary arterial hypertension to connective tissue disease (PAH-CTD): The TRUST study results.
    Denton, Christopher P.
    Gabrielli, Armando
    Peter, Hans-Hartmut
    Morganti, Adele
    Pope, Janet
    Guillevin, Loic
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S740 - S740
  • [5] Long-term efficacy and safety of bosentan in the treatment of ischemic digital ulcers due to severe Raynaud's phenomenon in patients with systemic sclerosis
    Alegre-Sancho, JJ
    Fernández-Llanio, N
    Hortal-Alonso, R
    Muñoz-Gil, S
    Pareja-Lázaro, MA
    Román-Ivorra, JA
    Abad-Franch, L
    Alcañiz-Escandell, C
    Chalmeta-Verdejo, C
    Fernández-Carballido, C
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 287 - 287
  • [6] Long-term effects of bosentan in pulmonary arterial hypertension related to connective tissue disease (PAH-CTD): The trust study results
    Denton, C. P.
    Gabrielli, A.
    Peter, H.
    Morganti, A.
    Pope, J. E.
    Guillevin, L.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1622 - 1622
  • [7] Measurement of soluble adhesion molecules in primary Raynaud's phenomenon and in Raynaud's phenomenon secondary to connective tissue diseases
    Brevetti, G
    De Caterina, M
    Martone, VD
    Corrado, S
    Silvestro, A
    Spadaro, G
    Scopacasa, F
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 2000, 30 (02): : 75 - 81
  • [8] Treatment with bosentan of pulmonary hypertension associated with connective tissue diseases: Long term results and safety
    Cozzi, F.
    Marotta, H.
    Pontarollo, S.
    Sarais, C.
    Tiso, F.
    Sfriso, P.
    Iliceto, S.
    Todesco, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 387 - 388
  • [9] Iloprost in the treatment of severe Raynaud's phenomenon in connective tissue diseases.
    Torres, C
    Cuadrado, MJ
    Ruiz-Irastorza, G
    Khamashta, MA
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S251 - S251
  • [10] Nailfold Videocapillaroscopy in Connective Tissue Diseases with Raynaud's Phenomenon in an Indian Population
    Sundaray, Sambit
    Mishra, Siddhartha
    Dash, Subhash Chandra
    Sundaray, Naba Kishore
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2022, 13 (01):
12345